Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

$ 15.50

4.8 (183) In stock

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials - ScienceDirect

Third Symposium on Primary Breast Cancer in Older Women

Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)

Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis

JCM, Free Full-Text

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients, Breast Cancer Research

Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

Frontiers Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis

Figure 3 from Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Young Filipino breast cancer patients have worse survival outcomes - ecancer